| Author (Corporate) | European Union Intellectual Property Office |
|---|---|
| Publisher | EU |
| Publication Date | September 2016 |
| Content Type | Report |
|
EUIPO is the European Union Intellectual Property Office responsible for managing the EU trade mark and the registered Community design. It also works with the IP offices of the EU Member States and international partners to offer a similar registration experience for trade marks and designs across Europe and the world. Until March 2016 it was called the Office for Harmonisation in the Internal Market (OHIM). This study focuses on the economic impact of counterfeit medicines in the European Union marketplace and its wider costs to industry, government and society as a whole. Fake medicines cost the EU pharmaceutical sector EUR 10.2 billion each year and the loss of 37 700 jobs. The study refers only to manufacturing and wholesale and does not include retailers (e.g. pharmacies). |
|
| Source Link | https://euipo.europa.eu/ohimportal/en/web/observatory/ipr-infringement-pharmaceutical-sector |
| Related Links |
|
| Subject Categories | Business and Industry, Internal Markets |
| Countries / Regions | Europe |
